BetterLife Pharma Inc. (BETRF)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

9 annual periodsNewest to oldest
201820172016201520132012201120102009
Research & development$70,304$58,041
Operating expenses$1.0M$6.0M$10.3M$117,484
Operating income−$1.0M−$6.0M−$10.3M−$117,484
EBITDAderived−$10.3M−$117,075
Net income−$121,182−$6.3M−$10.3M−$1.1M$341,425$1.4M−$3.0M−$120,134−$653,761
Basic EPSper diluted share$0.00-$0.08-$0.11-$0.10
Diluted EPSper diluted share$0.00-$0.08-$0.11-$0.10

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.